Company Profiles

IBA is your worldwide innovation leader in the field of proton therapy with future technologies such as DynamicARC® and ConformalFLASH® on our Proteus® platform. Thanks to our innovative mindset, we have remained ahead of the curve and built the largest community of proton therapy users who have treated more than 120,000 patients globally. Together we form the most knowledgeable proton therapy community in the world. We are not mere providers, we are real partners. Learn more on Campus - Your Proton Therapy Community.

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.

Varian has long been on a mission to help create a world without fear of cancer. Now, as a Siemens Healthineers company, we are working as one, based on a more expansive perspective of the patient's journey than ever before. As a result, our vision for the future – and what we can achieve on behalf of patients – has expanded and become much more comprehensive.

Given the broad portfolio of imaging and cancer care technologies and services that we offer as one unified company, we are working together to create an oncology

CQ Medical is the global leader in developing high-quality, innovative, patient-centric radiotherapy and cancer therapy solutions. Our company has more than 80 years of combined experience bringing advanced hardware and consumables for patient immobilization and positioning, fiducial markers, couchtops, and patient care products to the market.

DYNR US Inc. is the unique provider of the SDX System in the US. SDX System is a revolutionary solution for respiratory gating. SDX employs real-time monitoring and motion compensation techniques to tackle the challenges posed by respiratory motion during simulation and treatment. It can integrate with IBA Proteus One and Plus, Mevion S250i and Varian Probeam to synchronize the beam delivery with the patient's breathing cycle, ensuring optimal targeting of tumors while minimizing healthy tissue exposure. With its real-time tracking and personalized treatment options, SDX significantly enhances treatment accuracy and patient comfort.

Gold Anchor is a fiducial marker for soft tissue with proven clinical benefits. For proton therapy, Gold Anchor offers the following unique combination of benefits compared to alternatives:

  • Very low dose perturbation due to the ultrathin marker diameter.
  • Great kV-visibility compared to low density markers such as polymer or carbon markers.
  • Enhanced MR-visibility due to the unique and patented marker material, an alloy of gold and iron.
  • Industry-leading thin needle - 25G, 22G or 20G for Gold Anchor compared to 17G or 18G for most alternatives.
  • Anchoring marker design, allowing imaging for dose planning on the same day as implantation.

Klarity is at the forefront of radiotherapy technology and innovation. Klarity’s superior products and personalized service have established the company as a worldwide leader, providing clinics with improved solutions for patient positioning, treatment planning, brachytherapy, and custom devices.

Mevion Medical Systems is the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy. Since 2013, Mevion compact proton therapy single-room systems have been used by leading cancer centers for treating patients. Mevion's series of products, including the flagship MEVION S250i and MEVION S250-FIT* with HYPERSCAN pencil beam scanning, represent the world's most compact proton therapy systems that eliminate the obstacles of size, complexity, and cost. Mevion is headquartered in Littleton, Massachusetts with a presence in Europe and Asia. 

Orfit brings high precision and comfort to the positioning and immobilization of cancer patients in proton therapy thanks to devices that perfectly pair with advanced proton therapy delivery techniques. Aerial®, an award-winning proton couch top, optimizes the impact on proton dose. Combined with Nanor® masks we provide greater patient comfort while ensuring stability and reproducibility. 

RAD provides complex, design-built modular facilities for the healthcare industry. These customized, factory fabricated solutions are completed up to 50% faster than standard construction and are installed for temporary, interim or permanent use. Our facility solutions are rapidly deployable, can be relocatable and include radiotherapy vaults and clinics, proton centers, medical oncology facilities, sterile processing facilities and other specialty healthcare installations. Short term rentals are available as are unique financing options that require no capital.

Guiding Radiation Therapy

For more than 20 years, Vision RT has been on a mission to make radiation therapy more effective for cancer patients. 

We are the inventors of, and market leaders in, Surface Guided Radiation Therapy (SGRT) which uses 3D cameras to help guide radiation therapy at every step: Sim, Planning and Treatment.

Our systems are in active clinical use in more than 2,000 clinics globally, including all 15 of the USA’s 15 “Best Hospitals for Cancer.”

C4 Imaging pioneers cutting-edge MRI-positive signal markers, revolutionizing precision treatment planning and cancer therapy. Their flagship innovation, NOVA, stands alone as the premier MRI-positive signal fiducial marker, delivering precise daily treatment alignment, reduced dose perturbation, and pinpoint tumor localization for focal therapy. In addition to NOVA, C4 Imaging introduces Sirius and Orion, MRI-positive signal markers that excel in seed localization for Low Dose Rate (LDR) treatment and meticulous radiation dose delivery for High Dose Rate (HDR) therapy. These groundbreaking markers empower clinicians to provide unparalleled precision and effectiveness in cancer treatment, enhancing patient care and outcomes.

Proton Collaborative Group (PCG) is committed to improving the outcomes of cancer patients by working collectively to advance the role of particle radiotherapy in cancer treatment. PCG serves as the link between state-of-the-art treatment centers, expert physicians, innovative and high-quality collaborative research, and the largest and most comprehensive proton therapy database in the world.

PTCOG-NA Copyright © 2019. All Rights Reserved.
Powered by APPTIDE | Terms of Service